MiMedx Group's Total Assets for the quarter that ended in Dec. 2023 was $239.0 Mil.
During the past 12 months, MiMedx Group's average Total Assets Growth Rate was 48.90% per year.
During the past 3 years, the average Total Assets Growth Rate was 13.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 11.10% per year.
During the past 10 years, the average Total Assets Growth Rate was 7.90% per year.
During the past 13 years, MiMedx Group's highest 3-Year average Total Assets Growth Rate was 882.30%. The lowest was -14.80%. And the median was 26.70%.
The historical data trend for MiMedx Group's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
MiMedx Group's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
MiMedx Group's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
MiMedx Group Total Assets Related Terms
Thank you for viewing the detailed overview of MiMedx Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDXG has been successfully added to your 